At it again. They have no clue what the secondary endpoints accomplished. Perhaps they will "get it" when we cross $30 of get acquired for several billion. Wonder who they need to protect? Which pharmma pays them?
Anyone who writes them a check,they`re for hire,no better than a boiler room full of maggots.
Sentiment: Strong Buy